☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Rejects
The US FDA Rejects Mallinckrodt's Terlipressin Due to Doubts in its Risk-Benefit Profile
September 15, 2020
The US FDA Rejects Gilead's Filgotinib Due to Toxicity Issues
August 19, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
